MEME-B:CA:TSX-Manulife Multifactor Emerging Markets Index ETF (CAD)

ETF | Others |

Last Closing

CAD 31.35

Change

0.00 (0.00)%

Market Cap

N/A

Volume

200.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

N/A

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

-0.01 (-0.01%)

CAD 5.37B
XEQT:CA iShares Core Equity Portfolio

+0.01 (+0.03%)

CAD 4.78B
PHYS-U:CA Sprott Physical Gold Trust

-0.11 (-0.54%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.11 (+0.30%)

CAD 4.54B
HXT-U:CA Horizons S&P/TSX 60 Index ETF

N/A

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

-0.28 (-1.13%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

N/A

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

-0.08 (-0.35%)

CAD 2.78B
ZMMK:CA BMO Money Market Fund ETF Seri..

N/A

CAD 2.53B

ETFs Containing MEME-B:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.46% 74% C 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.46% 72% C 62% D
Trailing 12 Months  
Capital Gain 21.51% 57% F 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.51% 54% F 51% F
Trailing 5 Years  
Capital Gain 22.17% 42% F 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.17% 42% F 44% F
Average Annual (5 Year Horizon)  
Capital Gain 3.71% N/A N/A 51% F
Dividend Return 3.71% N/A N/A 46% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 15.16% N/A N/A 45% F
Risk Adjusted Return 24.44% N/A N/A 45% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike